Millennium Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $79.8M | Buy |
2,841,200
+1,124,200
| +65% | +$29.9M | 0.03% | 558 |
|
|
2025
Q4 | $42.8M | Sell |
1,717,000
-208,000
| -11% | -$5.25M | 0.02% | 911 |
|
|
2025
Q3 | $49M | Buy |
1,925,000
+219,500
| +13% | +$5.42M | 0.02% | 888 |
|
|
2025
Q2 | $41.3M | Sell |
1,705,500
-1,491,700
| -47% | -$34.8M | 0.02% | 944 |
|
|
2025
Q1 | $81M | Buy |
3,197,200
+2,373,400
| +288% | +$62.1M | 0.04% | 467 |
|
|
2024
Q4 | $21.9M | Sell |
823,800
-134,900
| -14% | -$3.66M | 0.01% | 1455 |
|
|
2024
Q3 | $27.7M | Sell |
958,700
-100,300
| -9% | -$2.93M | 0.01% | 1262 |
|
|
2024
Q2 | $29.6M | Sell |
1,059,000
-331,700
| -24% | -$9.13M | 0.01% | 1162 |
|
|
2024
Q1 | $38.6M | Sell |
1,390,700
-841,600
| -38% | -$23.4M | 0.02% | 1005 |
|
|
2023
Q4 | $64.3M | Buy |
2,232,300
+915,500
| +70% | +$27.7M | 0.03% | 643 |
|
|
2023
Q3 | $43.7M | Sell |
1,316,800
-962,100
| -42% | -$34M | 0.02% | 798 |
|
|
2023
Q2 | $83.6M | Buy |
2,278,900
+214,800
| +10% | +$8.36M | 0.04% | 446 |
|
|
2023
Q1 | $84.2M | Sell |
2,064,100
-37,800
| -2% | -$1.63M | 0.05% | 406 |
|
|
2022
Q4 | $108M | Buy |
2,101,900
+629,200
| +43% | +$30.2M | 0.06% | 343 |
|
|
2022
Q3 | $64.4M | Sell |
1,472,700
-10,500
| -0.7% | -$510K | 0.04% | 537 |
|
|
2022
Q2 | $77.8M | Buy |
1,483,200
+849,200
| +134% | +$43.3M | 0.05% | 411 |
|
|
2022
Q1 | $32.8M | Sell |
634,000
-147,700
| -19% | -$7.66M | 0.02% | 958 |
|
|
2021
Q4 | $46.2M | Sell |
781,700
-620,900
| -44% | -$30.8M | 0.02% | 771 |
|
|
2021
Q3 | $60.3M | Buy |
1,402,600
+690,100
| +97% | +$30.6M | 0.04% | 549 |
|
|
2021
Q2 | $27.9M | Buy |
712,500
+210,400
| +42% | +$8.18M | 0.02% | 941 |
|
|
2021
Q1 | $18.2M | Sell |
502,100
-793,100
| -61% | -$28.2M | 0.01% | 1173 |
|
|
2020
Q4 | $20.2M | Sell |
1,295,200
-145,829
| -10% | -$5.35M | 0.01% | 1057 |
|
|
2020
Q3 | $50.2K | Sell |
1,441,029
-139,444
| -9% | -$4.89M | 0.06% | 314 |
|
|
2020
Q2 | $49M | Buy |
1,580,473
+765,099
| +94% | +$26M | 0.07% | 295 |
|
|
2020
Q1 | $25.3M | Sell |
815,374
-666,866
| -45% | -$22.7M | 0.06% | 351 |
|
|
2019
Q4 | $55.1M | Buy |
1,482,240
+1,467,589
| +10,017% | +$52.3M | 0.07% | 325 |
|
|
2019
Q3 | $499K | Sell |
14,651
-445,315
| -97% | -$16.2M | ﹤0.01% | 3258 |
|
|
2019
Q2 | $18.9M | Buy |
459,966
+139,655
| +44% | +$5.55M | 0.03% | 827 |
|
|
2019
Q1 | $12.9M | Buy |
320,311
+109,511
| +52% | +$4.39M | 0.02% | 1089 |
|
|
2018
Q4 | $8.73M | Buy |
+210,800
| New | +$8.75M | 0.01% | 1213 |
|
|
2018
Q3 | – | Sell |
-421,600
| Closed | -$14.5M | – | 4187 |
|
|
2018
Q2 | $14.5M | Sell |
421,600
-368,900
| -47% | -$12.6M | 0.02% | 1067 |
|
|
2018
Q1 | $26.6M | Buy |
790,500
+579,700
| +275% | +$19.9M | 0.04% | 727 |
|
|
2017
Q4 | $7.24M | Buy |
+210,800
| New | +$7.19M | 0.01% | 1532 |
|
|
2015
Q2 | – | Sell |
-954,292
| Closed | -$31.5M | – | 3707 |
|
|
2015
Q1 | $31.5M | Buy |
+954,292
| New | +$30.3M | 0.06% | 432 |
|
|
2014
Q3 | – | Sell |
-129,958
| Closed | -$3.66M | – | 3934 |
|
|
2014
Q2 | $3.66M | Sell |
129,958
-3,445,421
| -96% | -$98.2M | 0.01% | 1392 |
|
|
2014
Q1 | $109M | Buy |
+3,575,379
| New | +$107M | 0.32% | 36 |
|
|
2013
Q4 | – | Sell |
-426,659
| Closed | -$11.6M | – | 3698 |
|
|
2013
Q3 | $11.6M | Sell |
426,659
-616,590
| -59% | -$16.8M | 0.04% | 608 |
|
|
2013
Q2 | $27.7M | Buy |
+1,043,249
| New | +$28.8M | 0.09% | 202 |
|
Other funds holding PFE
VCM
VPM
Millennium Management's PFE Position: Q1 2026 in Review
Millennium Management reduced its Pfizer (PFE) stake by 95% in Q1 2026, selling an estimated $49.3M and leaving 96,364 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3575.
Millennium Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $557M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Millennium Management held 96,364 shares of Pfizer worth $2.71M as of Q1 2026.
- Millennium Management sold 1,851,131 Pfizer shares in Q1 2026, an estimated $49.3M.
- Pfizer made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3575 holding.
- Millennium Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Pfizer position peaked at $557M in Q2 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.